María del Val
Toledo Lobo
Profesor/a Contratado/a Doctor/a
Jorge
Monserrat Sanz
Profesor/a Titular Universidad
Jorge Monserrat Sanz-rekin lankidetzan egindako argitalpenak (7)
2024
2022
-
Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn’s Disease Severity
Biomedicines, Vol. 10, Núm. 3
-
Prognostic role of IRS-4 in the survival of patients with pancreatic cancer
Histology and histopathology, Vol. 37, Núm. 5, pp. 449-459
2020
-
Extracellular allograft inflammatory factor-1 (AIF-1) potentiates Th1 cell differentiation and inhibits Treg response in human peripheral blood mononuclear cells from normal subjects
Human Immunology, Vol. 81, Núm. 2-3, pp. 91-100
2017
-
Infliximab therapy reverses the increase of allograft inflammatory factor-1 in serum and colonic mucosa of rats with inflammatory bowel disease
Biomarkers, Vol. 22, Núm. 2, pp. 133-144
2014
-
Effect of Infliximab in oxidised serum albumin levels during experimental colitis
Biomarkers, Vol. 19, Núm. 8, pp. 693-701
2013
-
Azathioprine desensitizes liver cancer cells to insulin-like growth factor 1 and causes apoptosis when it is combined with bafilomycin A1
Toxicology and Applied Pharmacology, Vol. 272, Núm. 3, pp. 568-578